Valganciclovir
RxNorm 275891
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 275891 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: valganciclovir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing valganciclovir (medicinal product)
(Atom ID: 9263893)
INPrescribable
Ingredient (IN):
Valganciclovir
(Atom ID: 1337264)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValGANciclovir
(Atom ID: 3731417)
PTPrescribable
Designated preferred name (PT):
Valganciclovir
(Atom ID: 1337270)
FNPrescribable
Full form of descriptor (FN):
Valganciclovir (substance)
(Atom ID: 1337274)
PTPrescribable
Designated preferred name (PT):
Valganciclovir-containing product
(Atom ID: 10822509)
Patient Education
Valganciclovir
Valganciclovir is used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people who have acquired immunodeficiency syndrome (AIDS). Valganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have received a heart, kidney, or kidney-pancreas transplant and who have a chance of getting CMV disease. Valganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.